Elicio Therapeutics, Inc. (ELTX)
2.565
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
2.565
0.00 (0.00%)
After-Hours: 17:53
Elicio Therapeutics Cash from Operations (TTM) : -37.69M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -37.69M |
| March 31, 2026 | -38.48M |
| December 31, 2025 | -36.95M |
| September 30, 2025 | -38.90M |
| June 30, 2025 | -35.09M |
| March 31, 2025 | -35.06M |
| December 31, 2024 | -37.07M |
| September 30, 2024 | -38.22M |
| June 30, 2024 | -36.13M |
| March 31, 2024 | -36.68M |
| December 31, 2023 | -32.69M |
| September 30, 2023 | -30.07M |
| Date | Value |
|---|---|
| June 30, 2023 | -30.28M |
| March 31, 2023 | -14.66M |
| December 31, 2022 | -22.18M |
| September 30, 2022 | -29.26M |
| June 30, 2022 | -39.08M |
| March 31, 2022 | -55.74M |
| December 31, 2021 | -52.64M |
| September 30, 2021 | -17.69M |
| June 30, 2021 | -24.43M |
| March 31, 2021 | -26.71M |
| December 31, 2020 | -22.89M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Precigen, Inc. | -114.16M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 12.48B |
| Anika Therapeutics, Inc. | 5.977M |
| BioCryst Pharmaceuticals, Inc. | 358.99M |